Drug delivery systems using polymer nanoassemblies for cancer treatment.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Therapeutic delivery

• Publication date

  2010-09-15

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.4155/TDE.10.28PMID 22816139
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spontaneous formation of nanosized unilamellar polyion complex vesicles with tunable size and properties.

  2010cited by this paper
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin.

  2009cited by this paper
• Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers.

  2009cited by this paper
• Active targeting schemes for nanoparticle systems in cancer therapeutics.

  2008cited by this paper
• Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug

  2008cited by this paper
• The origins and evolution of "controlled" drug delivery systems.

  2008cited by this paper
• Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling

  2007cited by this paper
• In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments.

  2007cited by this paper
• Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases

  2006cited by this paper
• Polymer therapeutics designed for a combination therapy of hormone-dependent cancer.

  2005cited by this paper
• Smart polymeric micelles for gene and drug delivery.

  2005cited by this paper
• Reversible covalent chemistry in drug delivery.

  2005cited by this paper
• Maladaptive Growth in the Failing Heart: The Cardiomyopathy of Overload

  2002cited by this paper
• Dissecting tumour pathophysiology using intravital microscopy

  2002cited by this paper
• Drug-polymer conjugates containing acid-cleavable bonds.

  1999cited by this paper
• Solvents and Self-Organization of Polymers

  1996cited by this paper
• Polymer conjugates with anticancer activity

  1995cited by this paper
• Tumoritropic and lymphotropic principles of macromolecular drugs.

  1989cited by this paper

• Quality Evaluation of Sustained-Release Domperidone Formulations

  2021cites this paper
• Estimation of Quality Characteristics for Sustained Releasing and Acting Formulation of Domperidone

  2021cites this paper
• Influence of different viscosity grade Methocel and Ethocel polymers for the development of controlled release dimenhydrinate matrix tablets

  2020cites this paper
• HALO- AND SOLVATO-FLUOROCHROMIC POLYMER NANOASSEMBLIES FOR CANCER THERANOSTICS

  2017cites this paper
• Development of Halofluorochromic Polymer Nanoassemblies for the Potential Detection of Liver Metastatic Colorectal Cancer Tumors Using Experimental and Computational Approaches

  2017cites this paper
• Development of Halofluorochromic Polymer Nanoassemblies for the Potential Detection of Liver Metastatic Colorectal Cancer Tumors Using Experimental and Computational Approaches

  2017cites this paper
• Comparison of Dialysis- and Solvatofluorochromism-Based Methods to Determine Drug Release Rates from Polymer Nanoassemblies

  2016cites this paper
• Tethered polymer nanoassemblies for sustained carfilzomib release and prolonged suppression of proteasome activity.

  2016cites this paper
• Oral and IV dosages of doxorubicin-methotrexate loaded- nanoparticles inhibit progression of oral cancer by down- regulation of matrix Methaloproteinase 2 expression in vivo.

  2015cites this paper
• DOX-MTX-NPs Augment p 53 mRNA Expression in OSCC Model in Rat : Effects of IV and Oral Routes Mehran

  2014cites this paper
• New formulated "DOX-MTX-loaded nanoparticles" down- regulate HER2 gene expression and improve the clinical outcome in OSCCs model in rat: the effect of IV and oral modalities.

  2014cites this paper
• DOX-MTX-NPs augment p53 mRNA expression in OSCC model in rat: effects of IV and oral routes.

  2014cites this paper
• Nanoparticles targeting mechanisms in cancer therapy; great efforts, less implementations.

  2013cites this paper
• Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions.

  2013cites this paper